REVELATION BIOSCIENCES INC (REVB) Stock Cash Flow
NASDAQ:REVB - Nasdaq - US76135L6065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.41M | -15.04M | -120.30K | -10.83M | -11.99M | |||
| Depreciation Amortization | 28.80K | 27.90K | 25.10K | 25.10K | 16.80K | |||
| Change In Working Capital | -4.28M | -3.42M | 982.10K | -731.00K | 356.20K | |||
| Other non cash items | 377.50K | 112.40K | -8.17M | 316.10K | 523.30K | |||
| OPERATING CASH FLOW | -18.28M | -18.32M | -7.29M | -11.22M | -11.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -19.20K | N/A | 0.00 | -132.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 25.74M | |||
| INVESTING CASH FLOW | 0.00 | -19.20K | N/A | 0.00 | -132.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -796.90K | 750.00K | |||
| Stock Issued/Repurchased | 7.43M | 12.85M | 14.03M | 4.46M | 8.00M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 11.53M | -25.70M | |||
| FINANCING CASH FLOW | 7.43M | 12.85M | 14.03M | 15.20M | 8.00M | |||
| CHANGE IN CASH | -10.85M | -5.49M | 6.74M | 3.98M | -3.22M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.28M | -18.32M | -7.29M | -11.22M | -11.09M | |||
| Capital Expenditure | 0.00 | -19.20K | N/A | 0.00 | -132.00K | |||
| FREE CASH FLOW | -18.28M | -18.34M | -7.29M | -11.22M | -11.22M | |||
All data in USD